Nanoform financial calendar for 2022
Company Announcement Nanoform Finland Plc December 10, 2021 04.45 p.m.…
Nanoform Interim Report January – September 2021
The strong momentum continues: all near-term business targets for 2021…
Resolutions of Nanoform Finland Plc’s Extraordinary General Meeting on November 17, 2021
Company release Nanoform Finland Plc November 17, 2021 03:00 p.m.…
Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021
Press release Nanoform Finland Plc November 17, 2021 10:15 a.m.…
Nanoform signs GMP agreement and achieves near-term business target
Insider information Nanoform Finland Plc November 15, 2021 05:05 p.m.…
Nanoform receives ISO/IEC 27001:2013 certification for its Information Security Management System
Press release Nanoform Finland Plc November 12, 2021 11:00 a.m.…
Invitation to presentation of Nanoform’s Q3/2021 report on November 25, 2021
Press release Nanoform Finland Plc November 11, 2021 11:00 a.m.…
Nanoform’s trailblazing progress earns recognition from prestigious industry awards
Our impressive achievements have been recognized across the board, with…
Nanoform convenes EGM to elect Jeanne Thoma as board member
Company Announcement Nanoform Finland Plc October 18, 2021 08:10 a.m.…
Notice to the Extraordinary General Meeting of NANOFORM FINLAND PLC
Company Announcement Nanoform Finland Plc October 18, 2021 08:10 a.m.…
Kutsu Nanoform Finland OyJ:n ylimääräiseen yhtiökokoukseen
Company Announcement Nanoform Finland Plc October 18, 2021 08:10 a.m.…
Nanoform receives funding to solve challenges for global health
Press release Nanoform Finland Plc September 29, 2021 03:45 p.m.…
Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade
Company release Nanoform Finland Plc Sep 24th, 2021 05.30 p.m.…
Nanoform shortlisted for the European Small and Mid-Cap Awards 2021
Press release Nanoform Finland Plc September 23, 2021 14:30 a.m.…
Nanoform technology delivers successful results for Herantis CDNF drug candidate
Press release Nanoform Finland Plc September 9, 2021 08:00 a.m.…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
Company release Nanoform Finland Plc August 27, 2021 04:30 p.m.…
Nanoform Interim Report January – June 2021
The strong momentum continues: Additional line capacity, more projects, new…
Invitation to presentation of Nanoform’s Q2/2021 report on August 26, 2021
Press release Nanoform Finland Plc August 12, 2021 11:00 a.m.…
Nanoform and Boehringer Ingelheim execute master services agreement
Press release Nanoform Finland Plc August 3, 2021 08:10 a.m.…
Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade
Company release Nanoform Finland Plc June 14, 2021 03:00 p.m.…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
Company release Nanoform Finland Plc June 11, 2021 06:15 p.m.…
Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs
Company release Nanoform Finland Plc June 11, 2021 06:15 p.m.…
Nanoform raises its mid-term business targets for 2025
Insider information Nanoform Finland Plc June 2, 2021 04:00 p.m.…
Nanoform Interim Report January – March (Q1) 2021
Strong momentum continues: three new non-GMP lines commissioned, four new…
Nanoform and Celanese Explore Ways to Enhance Drug Delivery
Press release Nanoform Finland Plc May 25, 2021 04:00 p.m.…
Cynthia Schwalm transitions to Senior Advisor Business Development US, from her role as member of the Board of Directors
Company Announcement Nanoform Finland Plc May 20, 2021 09:10 p.m.…
Nanoform’s final clinical results confirm value proposition to the pharma industry
Press release Nanoform Finland Plc May 18, 2021 08:10 a.m.…
Invitation to presentation of Nanoform’s Q1/2021 report on May 27, 2021
Press release Nanoform Finland Plc May 12, 2021 11:00 a.m.…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
Company release Nanoform Finland Plc May 11, 2021 08:00 p.m.…
Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
Press release Nanoform Finland Plc April 21st, 2021 08:10 a.m.…
Nanoform Finland Plc – Manager’s transactions – Gonçalo Andrade
Company release Nanoform Finland Plc April 8, 2021 06.30 p.m.…
Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs
Company release Nanoform Finland Plc April 7, 2021 5:30 p.m.…
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Company release Nanoform Finland Plc April 6, 2021 06:30 p.m.…
Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 6, 2021
Company release Nanoform Finland Plc April 6, 2021 11:00 a.m.…
Nanoform and Nacuity Pharmaceuticals Sign Technology Proof of Concept (“PoC”) Agreement for Two Ophthalmic Drug Candidates
Press release Nanoform Finland Plc March 31, 2021 08:10 a.m.…
Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®
Press release Nanoform Finland Plc March 22, 2021 08:10 a.m.…
NOTICE TO THE ANNUAL GENERAL MEETING OF NANOFORM FINLAND PLC
Company Announcement Nanoform Finland Plc March 10, 2021 23:00 Finnish…
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen
Yhtiötiedote Nanoform Finland Oyj 10.3.2021 klo 23.00 Suomen aikaa Kutsu Nanoform…
Nanoform Finland Plc: 5 633 803 new shares registered with the trade register
NOT FOR RELEASE, PUBLICATIONOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, INOR INTO…
Nanoform Finland Plc successfully completes new share issue raising EUR 40 million
Insider information Nanoform Finland Plc March 9, 2021 23:20 Finnish time…
Nanoform Finland Plc announces its intention to carry out a new share issue to raise approximately EUR 40 million
Insider information Nanoform Finland Plc March 9, 2021 18:30 Finnish…
Nanoform 1-12/2020 report and new company near-term target introduced
Company Announcement Nanoform Finland Plc February 26, 2021 08:10 a.m.…
Nanoform sets new near-term business target for 2021 and 2022
Insider information Nanoform Finland Plc February 26, 2021 08:05 a.m.…
Additional Positive Interim Results from Nanoform’s Clinical Study
Insider information Nanoform Finland Plc February 24, 2021 08:10 a.m.…
Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021
Press release Nanoform Finland Plc February 12, 2021 11:00 a.m.…
Nanoform and Herantis sign Biologics Proof of Concept Agreement
Press release Nanoform Finland Plc February 9th, 2021 08:10 a.m.…
Nanoform’s Clinical Study Indicates Positive Interim Results
Insider information Nanoform Finland Plc January 22nd, 2021 at 08.10…
Finnish Foundation for Share Promotion and Nasdaq Helsinki has chosen Nanoform as the company of the month (article in Finnish)
Helsinki, Finland – Finnish Foundation for Share Promotion (Pörssisäätiö/Börsstiftelsen) and…
Nanoform sets a new near-term business target for 2021
Insider information Nanoform Finland Plc January 4th, 2021 at 08.10…